Literature DB >> 21529830

Differentiating passive from transporter-mediated uptake by PepT1: a comparison and evaluation of four methods.

Jeffrey S Scow1, Srivats Madhavan, Rizwan M Chaudhry, Ye Zheng, Judith A Duenes, Michael G Sarr.   

Abstract

BACKGROUND: To quantify transmembrane transport of dipeptides by PepT1, passive uptake (non-PepT1 mediated) must be subtracted from total (measured) uptake. Three methods have been described to estimate passive uptake: perform experiments at cold temperatures, inhibit target dipeptide uptake with a greater concentration of a second dipeptide, or use modified Michaelis-Menten kinetics. We hypothesized that performing uptake experiments at pH 8.0 would estimate passive uptake accurately, because PepT1 requires a proton gradient. Our aim was to determine the most accurate method to estimate passive uptake.
METHODS: Caco-2 cells were incubated with various concentrations of glycyl-sarcosine (gly-sar) at pH 6.0 and at 37°C to measure total uptake. Passive uptake was estimated: (1) by incubating Caco-2 cells with varying concentrations of gly-sar at 4°C, (2) in the presence of 50 mM glycyl-leucine, (3) in solution at pH 8.0, or (4) using modified Michaelis-Menten kinetics. PepT1-mediated uptake was calculated by subtracting passive uptake from total uptake. K(m), V(max), and % gly-sar transported by PepT1 were calculated and compared.
RESULTS: K(m), V(max), and % gly-sar transported by PepT1 varied from 0.7 to 2.4 mM, 8.4 to 21.0 nmol/mg protein/10 min, and 69% to 87%, respectively. Uptakes calculated with cold, 50 mM gly-leu and using modified Michaelis-Menten kinetics were similar but differed significantly from uptake at pH 8.0 (P < 0.001).
CONCLUSIONS: Estimating passive uptake at pH 8.0 does not appear to be accurate. Measuring uptake at cold temperatures or in the presence of a greater concentration of a second dipeptide, and confirming results with modified Michaelis-Menten kinetics is recommended.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529830      PMCID: PMC3150389          DOI: 10.1016/j.jss.2011.02.018

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  35 in total

1.  Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.

Authors:  M Sugawara; W Huang; Y J Fei; F H Leibach; V Ganapathy; M E Ganapathy
Journal:  J Pharm Sci       Date:  2000-06       Impact factor: 3.534

2.  High-affinity interaction of sartans with H+/peptide transporters.

Authors:  Ilka Knütter; Gabor Kottra; Wiebke Fischer; Hannelore Daniel; Matthias Brandsch
Journal:  Drug Metab Dispos       Date:  2008-09-29       Impact factor: 3.922

3.  Role of vagal innervation in diurnal rhythm of intestinal peptide transporter 1 (PEPT1).

Authors:  Hisham G Qandeel; Fernando Alonso; David J Hernandez; Judith A Duenes; Ye Zheng; Jeffrey S Scow; Michael G Sarr
Journal:  J Gastrointest Surg       Date:  2009-08-26       Impact factor: 3.452

4.  Diurnal expression and function of peptide transporter 1 (PEPT1).

Authors:  Hisham G Qandeel; Judith A Duenes; Ye Zheng; Michael G Sarr
Journal:  J Surg Res       Date:  2009-05-03       Impact factor: 2.192

5.  Hexose transporter expression and function in mouse small intestine: role of diurnal rhythm.

Authors:  Javairiah Fatima; Corey W Iqbal; Scott G Houghton; Michael S Kasparek; Judith A Duenes; Ye Zheng; Michael G Sarr
Journal:  J Gastrointest Surg       Date:  2008-12-11       Impact factor: 3.452

6.  Interferon-gamma increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayers.

Authors:  David R Foster; Christopher P Landowski; Xiaomei Zheng; Gordon L Amidon; Lynda S Welage
Journal:  Pharmacol Res       Date:  2008-11-25       Impact factor: 7.658

7.  Oseltamivir (tamiflu) is a substrate of peptide transporter 1.

Authors:  Takuo Ogihara; Takashi Kano; Tamae Wagatsuma; Sho Wada; Hikaru Yabuuchi; Shigeki Enomoto; Kaori Morimoto; Yoshiyuki Shirasaka; Shoko Kobayashi; Ikumi Tamai
Journal:  Drug Metab Dispos       Date:  2009-05-13       Impact factor: 3.922

8.  Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.

Authors:  Ilka Knütter; Claudia Wollesky; Gabor Kottra; Martin G Hahn; Wiebke Fischer; Katja Zebisch; Reinhard H H Neubert; Hannelore Daniel; Matthias Brandsch
Journal:  J Pharmacol Exp Ther       Date:  2008-08-19       Impact factor: 4.030

9.  Expression and function of intestinal hexose transporters after small intestinal denervation.

Authors:  Corey W Iqbal; Javairiah Fatima; Judith Duenes; Scott G Houghton; Michael S Kasparek; Michael G Sarr
Journal:  Surgery       Date:  2009-05-08       Impact factor: 3.982

10.  Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity.

Authors:  Guillaume Dalmasso; Hang Thi Thu Nguyen; Yutao Yan; Laetitia Charrier-Hisamuddin; Shanthi V Sitaraman; Didier Merlin
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more
  2 in total

1.  Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.

Authors:  Zhiying Wang; Dhananjay Pal; Ashaben Patel; Deep Kwatra; Ashim K Mitra
Journal:  Int J Pharm       Date:  2012-12-20       Impact factor: 5.875

2.  Establishment and characterization of an omasal epithelial cell model derived from dairy calves for the study of small peptide absorption.

Authors:  Qingbiao Xu; Yueming Wu; Hongyun Liu; Yingming Xie; Xinbei Huang; Jianxin Liu
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.